Adhésion médicamenteuse en greffe rénale : évaluation, facteurs prédictifs et impact sur l’allo-réactivité humorale

Les données du rapport REIN. France REIN. https://www.francerein.org/actualites/23-les-donnees-du-rapport-rein.(consulté le 31/12/2020). Kidney Disease, 2009, KDIGO clinical practice guideline for the care of kidney transplant recipients, Am J Transplant, 9 Suppl 3, S1 Sabaté, 2003, 198 Denhaerynck, 2005, Prevalence, consequences, and determinants of nonadherence in adult renal transplant patients: a literature review, Transpl Int, 18, 1121, 10.1111/j.1432-2277.2005.00176.x Butler, 2004, Frequency and impact of nonadherence to immunosuppressants after renal transplantation: a systematic review, Transplantation, 77, 769, 10.1097/01.TP.0000110408.83054.88 Dobbels, 2010, The psychometric properties and practicability of self-report instruments to identify medication nonadherence in adult transplant patients: a systematic review, Transplantation, 90, 205, 10.1097/TP.0b013e3181e346cd Wiebe, 2015, Rates and determinants of progression to graft failure in kidney allograft recipients with de novo donor-specific antibody, Am J Transplant, 15, 2921, 10.1111/ajt.13347 Terasaki, 2004, Predicting kidney graft failure by HLA antibodies: a prospective trial, Am J Transplant, 4, 438, 10.1111/j.1600-6143.2004.00360.x Sellarés, 2012, Understanding the causes of kidney transplant failure: the dominant role of antibody-mediated rejection and nonadherence, Am J Transplant, 12, 388, 10.1111/j.1600-6143.2011.03840.x Wiebe, 2012, Evolution and clinical pathologic correlations of de novo donor-specific HLA antibody post kidney transplant, Am J Transplant, 12, 1157, 10.1111/j.1600-6143.2012.04013.x BAASIS–The Basel Assessment of Adherence to immunoSuppressive medIcations Scale. https://baasis.nursing.unibas.ch/.(consulté le 29/05/2021). Home - DIVAT. http://www.divat.fr/ (consulté le 03/05/2021). Le suivi immunologique des patients en attente de greffe d’organes ou greffés. Agence de la biomédecine. https://www.agence-biomedecine.fr/IMG/pdf/recommandations-concernant-le-suivi-immunologique-des-patients-en-attente-de-greffe-d-organes-ou-greffes.pdf. (consulté le 21/02/2022). Nomenclatures des professions et catégories socioprofessionnelles des emplois salariés des employeurs privés et publics. Insee. https://www.insee.fr/fr/information/2497958 (consulté le 03/05/2021). Dew, 2007, Rates and risk factors for nonadherence to the medical regimen after adult solid organ transplantation, Transplantation, 83, 858, 10.1097/01.tp.0000258599.65257.a6 Couzi, 2013, Factors predictive of medication nonadherence after renal transplantation: a French observational study, Transplantation, 95, 326, 10.1097/TP.0b013e318271d7c1 Nevins, 2017, Understanding medication nonadherence after kidney transplant, J Am Soc Nephrol, 28, 2290, 10.1681/ASN.2017020216 Allenet, 2013, Comment évaluer l’adhésion médicamenteuse ? Le point sur les méthodes, Ann Pharm Fr, 71, 135, 10.1016/j.pharma.2012.10.001 Osterberg, 2005, Adherence to medication, N Engl J Med, 353, 487, 10.1056/NEJMra050100 Farmer, 1999, Methods for measuring and monitoring medication regimen adherence in clinical trials and clinical practice, Clin Ther, 21, 1074, 10.1016/S0149-2918(99)80026-5 Éducation thérapeutique du patient par le pharmacien. Bibliographie. IREPS Haute Normandie. 2012. Allenet, 2018, Il nous faut arrêter de parler du patient « non observant » à ses traitements mais plutôt d’un patient présentant des difficultés d’adhésion médicamenteuse, Ann Pharm Fr, 76, 489, 10.1016/j.pharma.2018.07.006 Hsiau, 2011, Monitoring nonadherence and acute rejection with variation in blood immunosuppressant levels in pediatric renal transplantation, Transplantation, 92, 918, 10.1097/TP.0b013e31822dc34f Scheel, 2017, Patient-reported non-adherence and immunosuppressant trough levels are associated with rejection after renal transplantation, BMC Nephrol, 18, 107, 10.1186/s12882-017-0517-6 Tielen, 2014, Attitudes to medication after kidney transplantation and their association with medication adherence and graft survival: a 2-year follow-up study, J Transplant, 2014, 675301, 10.1155/2014/675301 Belaiche, 2017, Factors relevant to medication non-adherence in kidney transplant: a systematic review, Int J Clin Pharm, 39, 582, 10.1007/s11096-017-0436-4 Rebafka, 2016, Medication adherence after renal transplantation-a review of the literature, J Ren Care, 42, 239, 10.1111/jorc.12181 Villeneuve, 2020, Adherence profiles in kidney transplant patients: Causes and consequences, Patient Educ Couns, 103, 189, 10.1016/j.pec.2019.08.002 Pérez-San-Gregorio, 2005, Psychologic stages in renal transplant, Transplant Proc, 37, 1449, 10.1016/j.transproceed.2005.02.044 Lederer, 2005, Effects of mycophenolate mofetil on donor-specific antibody formation in renal transplantation, Clin Transplant, 19, 168, 10.1111/j.1399-0012.2005.00261.x Neuberger, 2017, Practical recommendations for long-term management of modifiable risks in kidney and liver transplant recipients: a guidance report and clinical checklist by the Consensus on Managing Modifiable Risk in Transplantation (COMMIT) group, Transplantation, 101, S1, 10.1097/TP.0000000000001651